Browsing by Author Price, K. N.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 9 of 9
Issue DateTitleAuthor(s)Citation
2008Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trialCoates, Alan; Altermatt, Hans J; Braye, Stephen; Castiglione-Gertsch, Monica; Del Curto, Barbara; Dell'Orto, Patrizia; Gelber, Richard D. (Prof); Goldhirsch, A; Gusterson, Barry; Henriksen, Katrine L; Lacroix-Triki, Magali; Lykkesfeldt, Anne E; Mastropasqua, Mauro G.; Mery, Eliane; Price, K. N.; Rasmussen, Brigitte B; Regan, Meredith M.; Thurlimann, Beat; Viale, Giuseppe; School of Public Health: Public HealthAdjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial, The Lancet, vol.9, N/A, 2008,pp 23-28
2009Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trialCoates, Alan; Campone, N; Castiglione-Gertsch, Monica; Forbes, John; Hawle, H; Mouridsen, Henning; Paridaens, R.J.; Price, K. N.; Rabaglio, Manuela; Sun, Zhuoxin; Thurlimann, Beat; School of Public Health: Public HealthBone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial, Annals of Oncology, vol.20, 9,pp 1489-1498
2011Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IX.Coates, Alan; Aebi, S; Braun, D; Castiglione-Gertsch, M; Crivellari, Diana; Gelber, Richard; Goldhirsch, A; Gusterson, B. A.; Karlsson, P; Lindtner, Jurii; Price, K. N.; Rabaglio, Manuela; Regan, Meredith M.; Simoncini, Edda; Snyder, Raymond; Sun, Z; Viale, Giuseppe; School of Public Health: Public HealthDifferential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IX., Annals of Oncology, vol.22, 9, 2011,pp 1981-1987
2008Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancerCoates, Alan; Castiglione-Gertsch, Monica; Cole, B F; Collins, John; Crivellari, Diana; Fey, Martin F.; Gelber, Richard D. (Prof); Goldhirsch, A; Golouh, Rastko; Gruber, G; Gusterson, Barry; Holmberg, Stig B.; Lindtner, Jurii; Price, K. N.; Simoncini, Edda; Thurlimann, Beat; School of Public Health: Public HealthExtracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer, Annals of Oncology, vol.19, N/A, 2008,pp 1393-1401
2006Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG).Coates, Alan; Castiglione-Gertsch, Monica; Collins, John; Crivellari, Diana; Fey, Martin F.; Gelber, Richard D. (Prof); Goldhirsch, Aron (Prof); Holmberg, Stig B.; Lindtner, Jurii; Murray, E.; Pagani, O.; Pestalozzi, B. C.; Price, K. N.; Simoncini, Edda; Zahrieh, David; School of Public Health: Public HealthIdentifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)., Annals of Oncology 2005, vol.17,(6),2006,pp 935-944
2011Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancerCoates, Alan; Braun, D; Castiglione-Gertsch, M; Collins, John; Crivellari, Diana; et al, various; Gelber, RD; Karlsson, Per; Price, K. N.; Rabaglio, Manuela; Sun, Zhuoxin; School of Public Health: Public HealthLong-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer, Annals of Oncology, vol.22, 10, 2011,pp 2216-2226
2009Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a century.Coates, Alan; Castiglione-Gertsch, Monica; Collins, John; et al, various; Fey, Martin F.; Gelber, RD; Holmberg, Stig B.; Lindtner, Jurij; Pagani, O.; Price, K. N.; Thurlimann, Beat; School of Public Health: Public HealthPatterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a century., Breast Cancer Research and Treatment, vol.117, 2,pp 319-324
2005Relation between chemotherapy dose, oestrogen receptor expression, and body-mass index.Coates, Alan; Castiglione-Gertsch, Monica; Colleoni, Marco; Gelber, Richard D. (Prof); Goldhirsch, A; Li, Sigui; Price, K. N.; School of Public Health: Public HealthRelation between chemotherapy dose, oestrogen receptor expression, and body-mass index., The Lancet, vol.366,(9491),2005,pp 1108-1110
2005Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer: role of endocrine responsiveness of the tumorCoates, Alan; Castiglione-Gertsch, Monica; Colleoni, Marco; Collins, John; Crivellari, Diana; Erzen, Darja; Forbes, John F.; Gelber, Richard D. (Prof); Goldhirsch, Aron (Prof); Holmberg, S.; Li, S.; Lindtner, Jurii; Murray, E.; Pagani, O.; Price, K. N.; Rudenstam, Carl-Magnus; Simoncini, Edda; Thurlimann, Beat; Veronesi, A.; School of Public Health: Public HealthTiming of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer: role of endocrine responsiveness of the tumor, Annals of Oncology 2005, vol.16,(5),2005,pp 716-725